Back to Editor profile » Dr Rony Avritscher
Dr Rony Avritscher
Dr Rony Avritscher
Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Rony Avritscher, MD Professor of Interventional Radiology at the University of Texas MD Anderson Cancer Center and co-chair of translational research for the Department of Interventional Radiology. Dr. Avritscher earned his medical degree from the University of Sao Paulo, in Sao Paulo, Brazil. He completed his radiology residency at the University of Texas Medical School at Houston and Interventional Radiology Fellowship at MD Anderson Cancer Center. He is certified by the American Board of Radiology and holds a Certificate of Added Qualification in Interventional Radiology.
His main research focus is in image-guided interventions for liver cancers, including translational research in animal models of liver disease and catheter-based therapies. He established an independent laboratory and is the recipient of a prestigious individual investigator-initiated grant awards from the American Cancer Society (ACS) and Cancer Prevention and Research Institute of Texas (CPRIT) focusing on characterizing the heterogeneous nature of liver tumor immune microenvironment after image-guided therapies, as well as implementing novel molecular and imaging approaches to reduce disease recurrence.
Dr. Avritscher is the current chair of research steering committee for the society of interventional oncology (SIO) and chair of the interventional radiology planning subcommittee for the Radiological Society of North America. He received the Editor’s Award for Outstanding Laboratory Investigation from the Journal of Vascular and Interventional Radiology, Distinguished Laboratory Investigation from the Society of Interventional Oncology, and Division of Imaging Outstanding Research Award for Basic and/or Translational Research from MD Anderson Cancer Center. Dr. Avritscher was elected a fellow of the Society of Interventional Radiology in 2018. His other interests include advanced hybrid suite imaging, lymphatic interventions, and cirrhosis.
Updated 14 March 2024
